Contact
Please use this form to send email to PR contact of this press release:
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
TO: